OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Quick
Links
Past Charts
Valuation Tracker By Industry Sector
Valuation Tracker By Sector
The Viridian Value Tracker is the most comprehensive valuation product in the industry.
-
- A broad set of 12 valuation measures assures applicability, regardless of whether the company has analyst coverage or revenues. The typically presented EV/ Projected Revenues and EV/ Projected EBITDA are available for less than 1/3 of the cannabis companies we track.
- Most valuation studies present only the average valuation measures, while the Tracker goes one step further and shows the distribution of values (the quartiles, median, and dispersion) for each measure. This gives users a more complete view of how companies in the cohort group are valued.
Week ended 01/24/2025
Sector Valuation – Psychedelics – After a long down spell from March 2024 through September 2024, the sector is back to August 2023 levels.
-
- The Psychedelics sector is back to trading at 1.07x book value.
- The performance of an equally weighted index composed of Mind Medicine (MMNM: Nasdaq), GH Research (GHRS: Nasdaq), Compass Pathways (CMPS: Nasdaq), Atai (ATAI: Nasdaq), Cybin (CYBN: Nasdaq), and Incannex (IXHL: Nasdaq) is depicted in the graph below.
Week ended 01/24/2025
Sector Valuation – Psychedelics – After a long down spell from March 2024 through September 2024, the sector is back to August 2023 levels.
-
- The Psychedelics sector is back to trading at 1.07x book value.
- The performance of an equally weighted index composed of Mind Medicine (MMNM: Nasdaq), GH Research (GHRS: Nasdaq), Compass Pathways (CMPS: Nasdaq), Atai (ATAI: Nasdaq), Cybin (CYBN: Nasdaq), and Incannex (IXHL: Nasdaq) is depicted in the graph below.
This Chart is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.